Calls selling into strength the high-conviction move: the asymmetry is ~2% upside to the $390.6 trigger vs. ~7–8% downside to the rising 50 SMA, against a resistance cluster that has already rejected price three times on unimpressive volume.
Concedes the $391 intraday stop is noise-prone and adopts a daily-close-above-$390.60 invalidation instead; ready to re-engage in full toward $430–$445 the moment that trigger fires on real volume.
Rejects both the $391 intraday stop (whipsaw risk) and the Conservative's wide $354.74-only stop (defers rather than reduces risk through a binary event at 175x earnings).
Proposes trimming toward the upper end (~40%) given event proximity and beta ~1.9; uses a daily close below $373.42/$370.66 (10 EMA/VWMA) as an early trim-further warning, and $354.74 as the structural cut-to-residual line. Re-entry: a starter position on a pre-earnings close above $390.6, or wait 1–2 sessions to confirm if the trigger fires on the earnings gap.
Agrees directionally with Underweight but calls the Aggressive sell-and-rebuy plan "tactical speculation dressed up as prudence" — a gap through $390.6 on an earnings beat means buying back at $395–$400, not $390.6, turning a cheap hedge into a self-inflicted 4–5% cost.
Votes to trim only one-third today, hold the residual with a stop below the rising 50 SMA ($354.74) rather than at $391, and wait for the Q3 print and midterms to settle before any automatic re-entry — collar the residual only if options costs are reasonable.
Executive summary: Underweight TSLA at $382.70 — trim the existing position by roughly one-third to one-half (~40% as the balanced midpoint; toward the upper end if risk-averse or concentrated in high-beta tech), executing into the $380–$387 strength shelf and taking the name to no more than about half of a standard single-name allocation. Do not initiate or add at current levels. Carry no new exposure into the Q3 print (~2 weeks out), and collar the residual ($365–$370 protective put funded by a $400–$410 covered call) only if the implied cost is acceptable — otherwise hold a smaller unhedged position.
Thesis: All three research voices agree on direction — reduce — and the disagreement is purely about magnitude and mechanics. The bear case wins the numbers (175x forward earnings vs. a 1.4% operating margin that has eroded six straight quarters, earnings quality propped up by non-operating FX/interest income, and a valuation math problem the bull never answered); the bull case wins the story (revenue re-acceleration to $28.24B, a fortress balance sheet with ~$27.4B net cash, a defined technical trigger at $390.6). Since a position decision settles on what you are paying versus what is confirmed, this is an Underweight — trim and reduce — not an exit.
Risk management: Manage the residual with close-based triggers, not intraday stops. A confirmed daily close above $390.60 on volume clearly above the ~25–40M/day range is the bull-side flip (reassess toward neutral/overweight, starter add targeting $430–$445). A daily close below the $373.42–$370.66 EMA/VWMA zone trims further; a daily close below the rising 50 SMA at $354.74 cuts to a minimal residual, next referencing $347–$348 and the ~$297–$298 July low.
Time horizon: 4–8 weeks, through the Q3 earnings print (~Oct 20) and the Nov 3 midterms, with mandatory re-underwrite on margin, free cash flow, and SBC/share-count trends at the print. Price target: not provided — the levels above are tactical references, not a valuation-derived forecast.